SKYSCRAPER-02: Primary Results of A Phase III, Randomized, Double-Blind, Placebo-Controlled Study of Atezolizumab (Atezo) Plus Carboplatin Plus Etoposide (CE) with or Without Tiragolumab (tira) in Patients (pts) With Untreated Extensive-Stage Small Cell Lung Cancer (ES-SCLC).

dc.contributor.authorRudin, Charles M.
dc.contributor.authorLiu, Stephen V.
dc.contributor.authorLu, Shun
dc.contributor.authorSoo, Ross A.
dc.contributor.authorHong, Min Hee
dc.contributor.authorLee, Jong-Seok
dc.contributor.authorBryl, Maciej
dc.contributor.authorDumoulin, Daphne W.
dc.contributor.authorRittmeyer, Achim
dc.contributor.authorChiu, Chao-Hua
dc.contributor.authorOzyilkan, Ozgur
dc.contributor.authorNavarro, Alejandro
dc.contributor.authorNovello, Silvia
dc.contributor.authorOzawa, Yuichi
dc.contributor.authorMeng, Raymond
dc.contributor.authorHoang, Tien
dc.contributor.authorLee, Anthony
dc.contributor.authorWen, Xiaohui
dc.contributor.authorHuang, Meilin
dc.contributor.authorReck, Martin
dc.date.accessioned2023-09-25T08:25:21Z
dc.date.available2023-09-25T08:25:21Z
dc.date.issued2022
dc.identifier.issn0732-183Xen_US
dc.identifier.issue17en_US
dc.identifier.urihttp://hdl.handle.net/11727/10786
dc.identifier.volume40en_US
dc.identifier.wos000891791500033en_US
dc.language.isoengen_US
dc.relation.journalJOURNAL OF CLINICAL ONCOLOGYen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleSKYSCRAPER-02: Primary Results of A Phase III, Randomized, Double-Blind, Placebo-Controlled Study of Atezolizumab (Atezo) Plus Carboplatin Plus Etoposide (CE) with or Without Tiragolumab (tira) in Patients (pts) With Untreated Extensive-Stage Small Cell Lung Cancer (ES-SCLC).en_US
dc.typeConference Objecten_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: